Kaleido Scope: UAB researchers are developing safer psychedelic-inspired therapeutics to treat depression and addiction
UAB researchers are developing safer psychedelic-inspired therapeutics to treat depression and addiction
Psychedelic and dissociative drugs can temporarily alter a person’s mood, thoughts, and perceptions. Among other health effects and safety concerns, people who use these substances report feeling strong emotions ranging from bliss to fear and experiencing vast changes in how they perceive reality.
Learn more about NIDA research on the therapeutic potential of psychedelic and dissociative drugs, including psilocybin. Along with other partners at the National Institutes of Health, NIDA is supporting research into psilocybin as a potential clinical treatment for substance use disorders and other mental illnesses.
Learn more about NIDA’s research on the health effects and therapeutic potential of psychedelic and dissociative drugs.
The Week: The growing popularity of psychedelic retreats raises questions of safety
Interest in psychedelics has surged, driven in part by their potential therapeutic applications. However, the mechanisms underlying these benefits remain debated. One perspective, the metaphysical ...
Forbes: 3 Reasons Why Safe Psychedelic Therapy Might Still Be A Distant Dream
3 Reasons Why Safe Psychedelic Therapy Might Still Be A Distant Dream
On Friday, the fledgling field of psychedelic medicine suffered a major setback. The FDA declined to approve MDMA-assisted therapy for PTSD, instead asking the drugmaker Lykos Therapeutics to conduct ...
If psychedelic-based therapies were to gain FDA approval, protocols to train clinicians will be needed for these therapies to enter mainstream psychiatric treatment, as well as questions answered about credentialing (i.e., what kinds of training, education, and experience qualify someone to deliver psychedelic-based therapy?).